Integrated analysis of hemorrhagic-thrombotic tendency.
D001537:Bencyclane / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000097:blood / Q000151:congenital; D001780:Blood Coagulation Tests; D003930:Diabetic Retinopathy / Q000097:blood; D004211:Disseminated Intravascular Coagulation / Q000097:blood; D005271:Femur Head Necrosis / Q000097:blood; D006330:Heart Defects, Congenital / Q000097:blood; D006391:Hemangioma / Q000097:blood; D006467:Hemophilia A / Q000097:blood; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood; D013921:Thrombocytopenia / Q000097:blood; D014511:Uremia / Q000097:blood; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology; D014842:von Willebrand Diseases / Q000097:blood
D001537:Bencyclane; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator